Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes

NCT03659799 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Insulin FiAsp
DRUG: Insulin Aspart
OTHER: 60-minutes postprandial exercise
OTHER: 120-minutes postprandial exercise

Sponsor

Institut de Recherches Cliniques de Montreal